Larvol Delta - Landscape-A-Phase-2-Openlabel-Study-to-Evaluate-the-Safety-of-Laruparetigene-Zovaparvovec-Administered-Bilaterally-in-Male-Participants-With-XLinked-Retinitis-Pigmentosa

laruparetigene zovaparvovec (AGTC-501) - Beacon Therapeutics

http://clinicaltrials.gov/ct2/show/NCT07174726

Jun 26, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Next